TwinKnowledge | $3,700,000 | (Apr 3, 2025)
experial | $2,198,930 | (Apr 3, 2025) Certified by Founder
Lodge
DISCO Pharmaceuticals GmbH
start up
Germany
- Cologne, North Rhine-Westphalia
- 17/01/2024
- Seed
- $21,727,000
DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies. These insights enable the development of a multitude of cancer-selective therapies, with the potential to boost efficacy and reducing side effects for patients.
- Industry Pharmaceutical Manufacturing
- Website https://discopharma.de/
- LinkedIn https://www.linkedin.com/company/disco-pharmaceuticals-gmbh/about/
Cambrian Network | $5,900,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
Further AI | $5,000,000 | (Apr 3, 2025)
Actively AI | $22,500,000 | (Apr 3, 2025)
Ropes | $3,100,000 | (Apr 3, 2025)
